India, June 30 -- Allergan Aesthetics, an AbbVie company (ABBV), Monday announced that the U.S. Food and Drug Administration (FDA) accepted for review the supplemental premarket approval (sPMA) application for Skinvive by Juvederm to reduce neck lines for the improvement of neck appearance.
Skinvive By Juvederm is currently approved in the U.S. to improve skin smoothness of the cheeks in adults over the age of 21.
"Skinvive By Juvederm is an injectable version of hyaluronic acid, a naturally occurring molecule found in the skin and important for skin hydration," said Darin Messina, Ph.D., senior vice president, aesthetics R&D, AbbVie. "The submission of Skinvive By Juvederm to treat neck lines demonstrates our continued focus on developin...